Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;70(2):133-42.
doi: 10.1093/gerona/glu021. Epub 2014 Mar 3.

Genetic analysis of TOR complex gene variation with human longevity: a nested case-control study of American men of Japanese ancestry

Affiliations

Genetic analysis of TOR complex gene variation with human longevity: a nested case-control study of American men of Japanese ancestry

Brian J Morris et al. J Gerontol A Biol Sci Med Sci. 2015 Feb.

Abstract

The mechanistic target of rapamycin (mTOR) pathway is crucial for life span determination in model organisms. The aim of the present study was to test tagging single-nucleotide polymorphisms that captured most of the genetic variation across key TOR complex 1 (TORC1) and TOR complex 2 (TORC2) genes MTOR, RPTOR, and RICTOR and the important downstream effector gene RPS6KA1 for association with human longevity (defined as attainment of at least 95 years of age) as well as health span phenotypes. Subjects comprised a homogeneous population of American men of Japanese ancestry, well characterized for aging phenotypes and who have been followed for 48 years. The study used a nested case-control design involving 440 subjects aged 95 years and older and 374 controls. It found no association of 6 tagging single-nucleotide polymorphisms for MTOR, 61 for RPTOR, 7 for RICTOR, or 5 for RPS6KA1 with longevity. Of 40 aging-related phenotypes, no significant association with genotype was seen. Thus common genetic variation (minor allele frequency ≥10%) in MTOR, RPTOR, RICTOR, and RPS6KA1 is not associated with extreme old age or aging phenotypes in this population. Further research is needed to assess the potential genetic contribution of other mTOR pathway genes to human longevity, gene expression, upstream and downstream targets, and clinically relevant aging phenotypes.

Keywords: Genetic association analysis; Health span; Life span; Longevity; Target of rapamycin..

PubMed Disclaimer

References

    1. Sebastiani P, Perls TT. The genetics of extreme longevity: lessons from the New England centenarian study. Front Genet. 2012;3:277. :10.3389/fgene - PMC - PubMed
    1. Beekman M, Blanché H, Perola M, et al. ; GEHA consortium. Genome-wide linkage analysis for human longevity: Genetics of Healthy Aging Study. Aging Cell. 2013;12:184–193. :10.1111/acel.12039 - PMC - PubMed
    1. Murabito JM, Yuan R, Lunetta KL. The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals. J Gerontol A Biol Sci Med Sci. 2012;67:470–479. :10.1093/gerona/gls089 - PMC - PubMed
    1. Mair W, Dillin A. Aging and survival: the genetics of life span extension by dietary restriction. Annu Rev Biochem. 2008;77:727–754. :10.1146/annurev.biochem.77.061206.171059 - PubMed
    1. Willcox BJ, Donlon TA, He Q, et al. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A. 2008;105:13987–13992. :10.1073/pnas.0801030105 - PMC - PubMed

Publication types

Substances